CHMP gives nod to GSK’s BCMA drug Blenrep for myeloma

GlaxoSmithKline is closing in on EU approval for its first-in-class BCMA-targeting drug Blenrep, after getting a green light from the EMA’s human medicines committee.

Novartis closes on EU approval for breast cancer drug Piqray

Novartis has moved nearer to claiming approval for its PI3K inhibitor Piqray for breast cancer in the EU, one of a crop of new drugs that the company thinks have blockbuster sa

Novartis on point in EU for asthma triple as CHMP backs Ener...

CHMP backs safety of anticoagulants after real-world study

Novartis closes on EU approval for SMA gene therapy Zolgensm...

Boehringer bags CHMP backing for Ofev in rare lung disease